Microbial or mammalian? BioSilta backs the former licensing E. Coli platform

08-Apr-2016 - Microbial expression systems are cheaper and more efficient than mammalian cell cultures says BioSilta which has acquired the rights to an E. coli based platform.

Eppendorf addressing stem cell scale-up challenges in Horizon 2020 project

08-Apr-2016 - Eppendorf will tackle the challenges of scaling-up human induced pluripotent stem cells (hiPSCs) as part of a Horizon 2020 project to develop cell-based heart therapies.

US Gov: Critical need for reproducible regenerative med manufacturing processes

06-Apr-2016 - Cell therapy firms must invest in engineering and learn from biopharma according to the US Government, which says high cost of regenerative treatments is slowing uptake.

GE and Zenith collaborate on bioprocessing automation

05-Apr-2016 - GE has teamed up with Zenith Technologies to implement automation across its single-use and modular bioprocessing technologies.

Merger prepares for 'tidal wave' of gene therapy products

31-Mar-2016 - Brammer Biopharmaceuticals and Florida Biologix have merged to create a cell and gene therapy biologics CDMO in preparation for a “tidal wave” of gene therapy products.

GE Healthcare launches Turkey-based R&D lab as economy booms

30-Mar-2016 - As Turkey becomes one of the world’s fastest growing economies, GE Healthcare launches collaborative research scheme to support Turkish biopharmaceutical industry.

BMS teams with Ireland's NIBRT to strengthen biomanufacturing processes

30-Mar-2016 - Bristol-Myers Squibb has announced plans to set up a biomanufacturing process laboratory in collaboration with Ireland's National Institute of Bioprocessing Research and Training (NIBRT).

To affinity and beyond: Space age flow cytometry tech could aid cell therapy firms says LeukoDx

29-Mar-2016 - Know-how underpinning the tech astronauts use to detect infections in space could streamline cell therapy manufacturing according to new GE Healthcare partner LeukoDx.

GE calls on diagnostics systems firm LeukoDx for cell characterization tech

25-Mar-2016 - LeukoDx will develop a cell characterization system for GE Healthcare in a deal designed to bolster the latter’s cell therapy manufacturing technology offering.

Biogen ups biologics capacity 73% through extra 144,000L at new Swiss plant

25-Mar-2016 - Biogen will equip its new Swiss biomanufacturing plant with eight 18,000L stainless steel bioreactors supplied by ABEC.

Novasep aims to fast-track mAb process development in GTP partnership

23-Mar-2016 - The partnership with recombinant protein development firm GTP Technologies will create an end-to-end manufacturing service, speeding up production of monoclonal antibodies and reducing costs, says Novasep.

Hitachi Chemical licenses PCT tech and mulls cell therapy JV

23-Mar-2016 - Hitachi Chemical has licensed cell therapy manufacturing technology from PCT in a deal that may see the firms set up a European JV.

GSK partners with Miltenyi Biotec to target CAR T cell therapy automation

18-Mar-2016 - GSK says the collaboration will attempt to overcome scale-up issues, a major concern among cell and gene therapy developers.

Time-saving benefit a factor in decision to go disposable, says Avid

16-Mar-2016 - The changeover time between batches is significantly quicker using disposable equipment, says Avid Bioservices whose new biomanufacturing facility boasts several 1,000L single-use bioreactors.

Pfizer invests $21m in Australian filgrastim plant

15-Mar-2016 - Pfizer has invested $21m to expand a plant in Adelaide, Australia which will manufacture a candidate biosimilar version of Amgen’s white blood cell booster, Neulasta.

CHO business: Lonza launches reformulated media for biopharma's go-to cell line

15-Mar-2016 - Lonza has launched a reformulated CHO media that it says supports the growth of higher density cultures and is easier to filter than currently available products.

Plant-based vaccines poised to challenge $4bn seasonal flu shot market

14-Mar-2016 - An influenza vaccine produced in tobacco plants could make a big impact in the market if it reaches the market in the US in time for the 2018-19 flu season,...

3D culturing key to bone marrow therapy for Fukushima clean-up workers

11-Mar-2016 - A bone marrow therapy available to workers cleaning up after the Fukushima nuclear plant meltdown relies on a novel bioreactor tech that cultures cells in 3D.

Peregrine: new biologics plant may boost contracting revenues by $40m

08-Mar-2016 - Avid Bioservices has formally commissioned a biologics manufacturing facility that more than doubles its production capacity.

Cell culture market to reach nearly $19bn by 2020

02-Mar-2016 - The global cell culture market is expected to reach $18,630.7m by 2020, up from $11,310.9m in 2015.

Criminals can manipulate drug production if IT systems not protected says expert

02-Mar-2016 - Hackers trying to steal drug formulae for counterfeiters can wreak havoc says an IT expert advocating stronger security for networked pharmaceutical manufacturing facilities.

32 tonnes, 8,500km, 18 months: JHL says off-the-shelf mAb plant to open in June

01-Mar-2016 - A mAb plant fabricated in Germany and shipped to China last year will be operational this summer according to Wuhan-based JHL Biotech. 

Second Vimizim manufacturing site ready mid-2017, BioMarin

26-Feb-2016 - BioMarin expects commercial production of its recently approved orphan drug Vimizim (elosulfase alfa) to begin at a secondary facility in Ireland – acquired from Pfizer – mid-2017.

Cobra Biologics and UK CPI team on AAV vector production platform

25-Feb-2016 - Cobra Biologics and the UK Centre for Process Innovation (CPI) will develop a manufacturing system for the viruses used to deliver gene therapies.

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Pall's Xpansion bioreactor chosen for 'world's largest cell bank' scale-up

23-Feb-2016 - Scaling-up without expanding its manufacturing footprint was key in selecting Pall's Xpansion bioreactor, says UCL which is looking to create “the world’s largest therapeutic cell bank.”